Sensus Healthcare Records Over 150% Jump In Q4 Sales

07:51pm, Friday, 11'th Feb 2022 Benzinga
Sensus Healthcare Inc''s (NASDAQ: SRTS ) Q4 FY21 sales increased 156% to $13 million , primarily driven by a higher number of units sold as the market continued to reopen, beating the consensus of $11.7 million. The gross profit margin improved to 68% of revenues, compared with $3.2 million, or 63.4% of revenues. The Company shipped a record 35 systems, including three … Full story available on Benzinga.com

Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates

10:55pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2021 Results - Earnings Call Transcript
Sensus Healthcare press release (NASDAQ:SRTS): Q4 GAAP EPS of $0.32 beats by $0.17.Revenue of $13.03M (+156.0% Y/Y) beats by $1.96M.Shares +7.25%.
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively

Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

08:01pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc are highlighted in this Screen of the Week article.
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Stride, Inc. (LRN), Euroseas Ltd.
Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of Sales Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling name

Sensus Healthcare, Inc. (SRTS) Just Reclaimed the 50-Day Moving Average

03:00pm, Wednesday, 26'th Jan 2022 Zacks Investment Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and n
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE